Hervé POILVACHE - NMSK IREC and TFAR FACM - In-vitro and in-vivo study of biofilm disruption strategies for the treatment of Prosthetic Joint Infections

Monday 20 September, 5.15 pm, Auditoire central Maisin Hervé POILVACHE NMSK - IREC and TFAR - FACM (Cellular and Molecular Pharmacology) In-vitro and in-vivo study of biofilm disruption strategies for the treatment of Prosthetic Joint Infections Directors: Olivier Cornu (NMSK - IREC) et Françoise Van Bambeke (TFAR - FACM) Related publications: Poilvache, H., et al. (2020).